Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Yes.
Salpeter
Shelley R
SR
D000318:Adrenergic beta-Agonists; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D000075202:Contraindications; D004341:Drug Evaluation; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D000068299:Salmeterol Xinafoate; D000420:Albuterol